{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-22-000010","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2022-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.026927+00:00","generated_at":"2026-06-27T13:16:00.475451+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeVantage Q2 revenue $52.2M, down 11.6% YoY; cuts FY2022 guidance","bullets":["Revenue $52.2M, down 11.6% YoY; EPS $0.01 diluted; adjusted EPS $0.05.","Active accounts fell 6.3% to 163,000; Americas down 11%, APAC up 6.4%.","FY2022 revenue guidance reduced to $212-220M (prev $225-235M); adj. EBITDA $18-20M (prev $22-24M).","Repurchased ~0.5M shares for $3.2M in Q2; balance sheet strong with $20.2M cash, no debt.","Appointed new CMO and CDO to senior leadership team."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-22-000010","json":"https://secwatch.observer/filing/0000849146-22-000010.json","markdown":"https://secwatch.observer/filing/0000849146-22-000010.md","text":"https://secwatch.observer/filing/0000849146-22-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914622000010/0000849146-22-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914622000010/lfvn-20220201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T13:16:00.475451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}